Paediatric Syncope in the Emergency Department
Launched by DR. VICTORIA CLAYDON · Sep 22, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Paediatric Syncope in the Emergency Department," is studying how effective certain techniques called counterpressure maneuvers (CPM) are in preventing fainting episodes (syncope) in children and teenagers. If your child is aged between 6 and 18 years and has recently experienced a brief loss of consciousness, they may be eligible to participate. The trial takes place in the emergency department, where participants will first complete a short survey about their fainting experience. Those who choose to continue will either receive regular care or be taught CPM techniques, which include leg crossing, bending, and arm tensing, to help prevent future fainting.
Participants will be followed for a year, during which they will fill out monthly surveys about any new fainting episodes. The study aims to gather information on how these techniques might help young patients and whether they lead to any changes in their medical condition. It's important to note that certain medical histories, like heart conditions or recent seizures, may exclude a child from joining the study. Overall, this trial could provide valuable insights into managing fainting in children and improving their health outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Those between the ages of 6-18 years (inclusive)
- • 2. Presenting to the ED daily 1000-2200 with resolved transient loss of consciousness that has occurred within the last week
- • 3. Able to complete the survey in English
- • 4. Willing and able to provide consent and assent
- Exclusion Criteria:
- 1. Those with a known history of any of the following:
- • Suspected or confirmed cardiac arrhythmia diagnosis (e.g., Wolff-Parkinson-White, long QT)
- • Traumatic head injury
- • New presentation of seizure disorder
- • Epilepsy recurrence
- • Overdose, intoxication
- • Structural heart disease
- • 2. Patients with hypoglycaemia and who are psychogenic with vasovagal syncope who do not present with prodromal symptoms
- • 3. Previously enrolled in this study
About Dr. Victoria Claydon
Dr. Victoria Claydon is a distinguished clinical trial sponsor with extensive expertise in the field of clinical research. She is dedicated to advancing medical knowledge and improving patient outcomes through rigorous study design and implementation. Dr. Claydon's commitment to ethical standards and regulatory compliance ensures that all trials are conducted with the highest level of integrity. With a focus on innovative therapies and patient-centered approaches, she collaborates with a diverse range of stakeholders to drive successful trial execution and contribute to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Shubhayan Sanatani, MD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials